Experience

• 

  Mercy

  Jun 2020 - Aug 2021

  Pharmacy technician

  Managed insurance coverage issues, prior authorizations, and drug shortages to advocate for patient health literacy, outcomes, and medication adherence Communicated with patients to ensure proper medication therapy and insurance coverage Handled incoming and outgoing phone calls to and from patients and doctor’s offices to address concerns with medications, insurance coverage, and adverse reactions

• 

  Saint luke's health system

  Aug 2021 - now

  Inpatient pharmacy intern

  Collaborate in training committee to train interns and technicians on pharmacy operations to grow personal leadership and management skills while ensuring standardization across teams Complete prior to admission medication histories and medication educations on high-risk patients to avoid errors and improve patient outcomes Analyze medication overrides to determine if they are valid and medications are on policy while ensuring formulary compliance and reducing costs

• 

  Goldsmith medicenter pharmacy

  Jun 2022 - Jul 2022

  Pharmacy intern

  Educated patients on correct usage, side effects, and benefits of various oral and compounded medications to ensure efficacy and safety of medication usage Analyzed medication profiles for adherence, potential drug interactions, and therapy duplication to avoid medication errors and to confirm patient safety Compounded specialty creams, capsules, and other dosage forms for patients

• 

  Eli lilly and company

  Jun 2023 - Aug 2023

  Diabetes graduate speciality sales intern

  Effectively utilized value-based selling to communicate and build authentic relationships and trust with endocrinologists, advanced practice providers, diabetes educators, and office staff to deliver specific product information on Mounjaro® clinical trial results and the appropriate brand patient while uncovering limiting and enabling beliefs related to diabetes products Analyzed diabetes product and market trends to develop effective communication strategies and territory business plans, while collaborating with territory partners to enhance patient-focused product messaging, build HCP relationships, and drive business growthCompleted business analysis and capstone presentations to analyze incretin prescribing trends in the territory, future commercial strategies, and a SWOT analysis of US diabetes sales Show less

• 

  U.s. department of veterans affairs

  Aug 2023 - May 2024

  Ambulatory care pharmacy intern

  Interviewed patients to collect social history and medications to prepare an individualized patient care plan and push for the best possible care for each disease state Collected information from patient charts to produce a patient specific plan for each disease state and presented plan to pharmacists and residents

• 

  Saint luke's hospital - saint louis

  Dec 2023 - Jan 2024

  Inpatient pharmacy intern

  Completed Holding Medications for Specific Procedures Policy Update to promote patient safety during surgical procedures Analyzed and updated current insulin dispensing and nurse administration policies to promote increased cost savings and patient safety

• 

  Bristol myers squibb

  Jun 2024 - Jun 2024

  Early clinical development - hematology/oncology and cellular therapy

  Presented on prostate cancer treatment/competitive landscape, guideline review, and prostate cancer phase 1 molecule ASCO abstract to educate clinical scientists and trial managers on clinical implications post-approval Utilized Medidata Rave to clean phase 1 clinical trial screening, safety, and efficacy data to ensure integrity and continuity of the trial Updated PSA and EKG values weekly and optimized method for recording PSA percent change and adding new patients to track efficacy and safety across patient cohorts Participated in patient eligibility reviews, investigator calls, and medical monitoring to track patient safety, drug efficacy, and compliance with trial inclusion/exclusion criteria and overall trial protocol Reviewed and standardized adverse event reporting for trial sites to homogenize site reported adverse event coding Show less

• 

  Eli lilly and company

  Jul 2024 - Jul 2024

  Global medical affairs - diabetes and obesity

  Presented the survey-based study “Evaluating Patient and Provider Preferences for a Once-Weekly Basal Insulin in Adults with Type 2 Diabetes” to medical, marketing, and HEOR teams, aiding competitive intelligence and shaping the phase 3 pre-launch medical strategy for insulin efsitora alfaAnalyzed patient reported outcomes from a phase 3 clinical trial program to inform future data disclosures and cost-utility analysis Contributed to diabetes pre-launch medical strategy development including advisory board preparation, congress preparation, thought leader engagement, updates on competitor NDA submission progress, and development of medical page content Collaborated internally and externally to create a slide deck resource to be utilized internally for training and externally by MSLs to ensure consistent understanding of MOA, drug class, and clinical trials Participated in medical, legal, and regulatory review of promotional materials for a once-weekly insulin in phase 3 development, ensuring accurate and relevant messaging for patients and HCPs Prepared fair, balanced, and accurate responses to unsolicited medical information questions to address HCP understanding of appropriate patient use Show less